To overcome the lack of syngeneic mouse models susceptible to oBHV, we used B16-C10 cells [28], genetically engineered B16 mouse melanoma cells expressing nectin-1, a human BHV-1 entry receptor [29]. The gene discussed is NECTIN1; the disease is melanoma.